Related Experiment Video
Updated: Jun 9, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site
Jianhong Ma1, John D Martin, Yu Xue
1GlaxoSmithKline, King of Prussia, PA 19406, USA. jane.2.ma@gsk.com
Abstract:
USP7, also known as the hepes simplex virus associated ubiquitin-specific protease (HAUSP), deubiquitinates both mdm2 and p53, and plays an important role in regulating the level and activity of p53. Here, we report that deletion of the TRAF-like domain at the N-terminus of USP7, previously reported to contain the mdm2/p53 binding site, has no effect on USP7 mediated deubiquitination of Ub(n)-mdm2 and Ub(n)-p53. Amino acids 208-1102 were identified to be the minimal length of USP7 that retains proteolytic activity, similar to full length enzyme, towards not only a truncated model substrate Ub-AFC, but also Ub(n)-mdm2, Ub(n)-p53. In contrast, the catalytic domain of USP7 (amino acids 208-560) has 50-700 fold less proteolytic activity towards different substrates. Moreover, inhibition of the catalytic domain of USP7 by Ubal is also different from the full length or TRAF-like domain deleted proteins. Using glutathione pull-down methods, we demonstrate that the C-terminal domain of USP7 contains additional binding sites, a.a. 801-1050 and a.a. 880-1050 for mdm2 and p53, respectively. The additional USP7 binding site on mdm2 is mapped to be the C-terminal RING finger domain (a.a. 425-491). We propose that the C-terminal domain of USP7 is responsible for maintaining the active conformation for catalysis and inhibitor binding, and contains the prime side of the proteolytic active site.
Insights
The ubiquitin-specific protease 7 (USP7) C-terminal domain binds mdm2 and p53, maintaining its catalytic activity. Deleting the N-terminal TRAF-like domain does not affect USP7
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Ubiquitin-specific protease 7 (USP7), also known as HAUSP, regulates p53 levels by deubiquitinating mdm2 and p53.
- The N-terminal TRAF-like domain of USP7 was previously thought to be crucial for mdm2/p53 binding.
Purpose of the Study:
- To investigate the functional role of USP7 domains in deubiquitination and substrate binding.
- To identify the minimal catalytic domain and additional binding sites of USP7.
Main Methods:
- Site-directed mutagenesis to delete the N-terminal TRAF-like domain of USP7.
- Enzyme kinetics assays using Ub-AFC, Ub(n)-mdm2, and Ub(n)-p53 substrates.
- Glutathione S-transferase (GST) pull-down assays to map protein-protein interaction domains.
Main Results:
- Deletion of the USP7 N-terminal TRAF-like domain did not impair deubiquitination of mdm2 and p53.
- The minimal functional USP7 enzyme spans amino acids 208-1102, retaining proteolytic activity.
- The C-terminal domain of USP7 contains specific binding sites for mdm2 (a.a. 801-1050) and p53 (a.a. 880-1050).
- The catalytic domain (a.a. 208-560) showed significantly reduced proteolytic activity compared to full-length or truncated USP7.
Conclusions:
- The N-terminal domain is not essential for USP7-mediated deubiquitination of mdm2 and p53.
- The C-terminal domain of USP7 is critical for maintaining catalytic activity, substrate binding, and inhibitor interaction.
- USP7's C-terminal region likely stabilizes the enzyme's active conformation.
More Related Videos
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...